Harbin Honor Pharmaceutical Co., Ltd.
Securities Code: 002437 Securities Abbreviation: Honor Pharmaceutical Announcement No.: 2026-036
Harbin Honor Pharmaceutical Co., Ltd. 2026 First Quarter Report
The Company and all members of the Board of Directors guarantee the information disclosed in the report is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.
Key Information Prompt:
- The Board of Directors and its members, and senior management guarantee the truthfulness, accuracy, and completeness of the quarterly report, and that there are no false records, misleading statements, or material omissions, and they shall bear individual and joint legal liabilities.
- The Company's principal, the person in charge of accounting, and the head of the accounting department (chief accountant) declare: Guarantee the truthfulness, accuracy, and completeness of the financial information in the quarterly report.
- Has the first quarter financial accounting report been audited? □ Yes ☑ No
I. Major Financial Data
(I) Key Accounting Data and Financial Indicators
Does the Company need to retrospectively adjust or restate prior year accounting data? □ Yes ☑ No
| Item | Current Reporting Period | Prior Year Period | Year-on-Year Change (%) |
|---|---|---|---|
| Operating Revenue (RMB) | 539,105,711.33 | 551,255,672.12 | -2.20% |
| Net Profit Attributable to Shareholders of the Parent Company (RMB) | 94,926,073.47 | 60,252,267.26 | 57.55% |
| Net Profit Attributable to Shareholders of the Parent Company, Net of Non-recurring Gains and Losses (RMB) | 62,942,231.17 | 49,733,030.46 | 26.56% |
| Net Cash Flow from Operating Activities (RMB) | 72,710,289.28 | 106,474,494.15 | -31.71% |
| Basic Earnings Per Share (RMB/share) | 0.0433 | 0.0274 | 58.03% |
| Diluted Earnings Per Share (RMB/share) | 0.0425 | 0.0266 | 59.77% |
| Weighted Average Return on Equity | 4.05% | 3.08% | 0.97% |